The Influences of Blood Flow Restriction on Leg Press
1 other identifier
interventional
30
1 country
1
Brief Summary
This study will investigate the use of different blood flow restriction cuffs during leg press exercise on arterial stiffness, muscle morphology, performance, and participant perception.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 26, 2025
CompletedFirst Posted
Study publicly available on registry
July 4, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedJuly 4, 2025
June 1, 2025
3 months
June 26, 2025
June 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Pulse wave velocity
10 minutes before and 10 minutes after the exercise intervention
Study Arms (3)
Delfi
EXPERIMENTALFitcuff
EXPERIMENTALControl
PLACEBO COMPARATORInterventions
Leg press exercise with Delfi blood flow restriction cuff
Eligibility Criteria
You may qualify if:
- Physically active (\> 1,000 MET/min/wk) for at least six months.
- Weight stable for previous 6 months (+/-2.5 kg)
You may not qualify if:
- Stage 2 hypertension (SBP \>/= 140 and/or DBP \>/= 90 mmHg)
- BMI\>40 kg/m2
- Diabetes
- Familial hypercholesterolemia
- Past or current history of CHD, stroke or major CVD events. Respiratory diseases (not including asthma), endocrine or metabolic, neurological, or hematological disorders that would compromise the study or the health of the subject.
- Participants must not be pregnant, plan to become pregnant during the study, or be nursing
- Active renal or liver disease
- All medications and supplements that influence dependent variables\*
- Recent surgery \< 2 months
- Alcohol abuse
- Sleep apnea
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Salisbury University
Salisbury, Maryland, 21801, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
June 26, 2025
First Posted
July 4, 2025
Study Start
September 1, 2025
Primary Completion
December 14, 2025
Study Completion
December 15, 2025
Last Updated
July 4, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
Excel spreadsheet with data will be shared upon request.